Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer

Liwei Wang, Xiaohong Guan, Weida Gong, James Yao, Zhihai Peng, Daoyan Wei, Tsung Teh Wu, Suyun Huang, Keping Xie

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Our recent study has shown that transcription factor Sp1 is an independent prognostic factor in gastric cancer. However, it is unclear how Sp1 impacts gastric cancer biology. Since Sp1 regulates multiple genes important to angiogenesis, we sought to evaluate the relationship between Sp1 expression and microvessel density (MVD) as well as their effects on cancer patient survival. The expression of Sp1 and status of MVD was determined using archival tissues of 86 cases of resected human gastric cancer. We found that MVD correlated highly with Sp1 expression (P < 0.001). Patients with strong Sp1 expression were 12 times more likely to have high MVD than were those with negative Sp1 expression. In univariate survival analyses, both elevated Sp1 expression (P = 0.007) and high MVD expression (P = 0.036) were associated with inferior survival. However, when Sp1 expression, MVD expression, disease stage, completeness of resection, Lauren's classification, and patient age were entered into a Cox proportional hazards model, only strong Sp1 expression (P = 0.047) and advanced stage (P < 0.01) were independently prognostic of poor survival. Furthermore, knocking down Sp1 expression significantly impaired the angiogenic potential of tumor cells in vitro and suppressed angiogenesis in vivo animal models. Therefore, we provided both clinical and experimental evidence to indicate that Sp1 might impact gastric cancer development and progression through regulating angiogenesis, a critical aspect of cancer biology.

Original languageEnglish (US)
Pages (from-to)205-213
Number of pages9
JournalClinical and Experimental Metastasis
Volume22
Issue number3
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Sp1 Transcription Factor
Microvessels
Stomach Neoplasms
Phenotype
Survival
Neoplasms
Survival Analysis
Proportional Hazards Models
Animal Models
Genes

Keywords

  • Angiogenesis
  • Metastasis
  • Prognosis
  • Transcription factor
  • Tumor

ASJC Scopus subject areas

  • Cancer Research

Cite this

Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. / Wang, Liwei; Guan, Xiaohong; Gong, Weida; Yao, James; Peng, Zhihai; Wei, Daoyan; Wu, Tsung Teh; Huang, Suyun; Xie, Keping.

In: Clinical and Experimental Metastasis, Vol. 22, No. 3, 01.2005, p. 205-213.

Research output: Contribution to journalArticle

Wang, Liwei ; Guan, Xiaohong ; Gong, Weida ; Yao, James ; Peng, Zhihai ; Wei, Daoyan ; Wu, Tsung Teh ; Huang, Suyun ; Xie, Keping. / Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. In: Clinical and Experimental Metastasis. 2005 ; Vol. 22, No. 3. pp. 205-213.
@article{a645836ad380406184531d081bbe932e,
title = "Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer",
abstract = "Our recent study has shown that transcription factor Sp1 is an independent prognostic factor in gastric cancer. However, it is unclear how Sp1 impacts gastric cancer biology. Since Sp1 regulates multiple genes important to angiogenesis, we sought to evaluate the relationship between Sp1 expression and microvessel density (MVD) as well as their effects on cancer patient survival. The expression of Sp1 and status of MVD was determined using archival tissues of 86 cases of resected human gastric cancer. We found that MVD correlated highly with Sp1 expression (P < 0.001). Patients with strong Sp1 expression were 12 times more likely to have high MVD than were those with negative Sp1 expression. In univariate survival analyses, both elevated Sp1 expression (P = 0.007) and high MVD expression (P = 0.036) were associated with inferior survival. However, when Sp1 expression, MVD expression, disease stage, completeness of resection, Lauren's classification, and patient age were entered into a Cox proportional hazards model, only strong Sp1 expression (P = 0.047) and advanced stage (P < 0.01) were independently prognostic of poor survival. Furthermore, knocking down Sp1 expression significantly impaired the angiogenic potential of tumor cells in vitro and suppressed angiogenesis in vivo animal models. Therefore, we provided both clinical and experimental evidence to indicate that Sp1 might impact gastric cancer development and progression through regulating angiogenesis, a critical aspect of cancer biology.",
keywords = "Angiogenesis, Metastasis, Prognosis, Transcription factor, Tumor",
author = "Liwei Wang and Xiaohong Guan and Weida Gong and James Yao and Zhihai Peng and Daoyan Wei and Wu, {Tsung Teh} and Suyun Huang and Keping Xie",
year = "2005",
month = "1",
doi = "10.1007/s10585-005-5684-3",
language = "English (US)",
volume = "22",
pages = "205--213",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer

AU - Wang, Liwei

AU - Guan, Xiaohong

AU - Gong, Weida

AU - Yao, James

AU - Peng, Zhihai

AU - Wei, Daoyan

AU - Wu, Tsung Teh

AU - Huang, Suyun

AU - Xie, Keping

PY - 2005/1

Y1 - 2005/1

N2 - Our recent study has shown that transcription factor Sp1 is an independent prognostic factor in gastric cancer. However, it is unclear how Sp1 impacts gastric cancer biology. Since Sp1 regulates multiple genes important to angiogenesis, we sought to evaluate the relationship between Sp1 expression and microvessel density (MVD) as well as their effects on cancer patient survival. The expression of Sp1 and status of MVD was determined using archival tissues of 86 cases of resected human gastric cancer. We found that MVD correlated highly with Sp1 expression (P < 0.001). Patients with strong Sp1 expression were 12 times more likely to have high MVD than were those with negative Sp1 expression. In univariate survival analyses, both elevated Sp1 expression (P = 0.007) and high MVD expression (P = 0.036) were associated with inferior survival. However, when Sp1 expression, MVD expression, disease stage, completeness of resection, Lauren's classification, and patient age were entered into a Cox proportional hazards model, only strong Sp1 expression (P = 0.047) and advanced stage (P < 0.01) were independently prognostic of poor survival. Furthermore, knocking down Sp1 expression significantly impaired the angiogenic potential of tumor cells in vitro and suppressed angiogenesis in vivo animal models. Therefore, we provided both clinical and experimental evidence to indicate that Sp1 might impact gastric cancer development and progression through regulating angiogenesis, a critical aspect of cancer biology.

AB - Our recent study has shown that transcription factor Sp1 is an independent prognostic factor in gastric cancer. However, it is unclear how Sp1 impacts gastric cancer biology. Since Sp1 regulates multiple genes important to angiogenesis, we sought to evaluate the relationship between Sp1 expression and microvessel density (MVD) as well as their effects on cancer patient survival. The expression of Sp1 and status of MVD was determined using archival tissues of 86 cases of resected human gastric cancer. We found that MVD correlated highly with Sp1 expression (P < 0.001). Patients with strong Sp1 expression were 12 times more likely to have high MVD than were those with negative Sp1 expression. In univariate survival analyses, both elevated Sp1 expression (P = 0.007) and high MVD expression (P = 0.036) were associated with inferior survival. However, when Sp1 expression, MVD expression, disease stage, completeness of resection, Lauren's classification, and patient age were entered into a Cox proportional hazards model, only strong Sp1 expression (P = 0.047) and advanced stage (P < 0.01) were independently prognostic of poor survival. Furthermore, knocking down Sp1 expression significantly impaired the angiogenic potential of tumor cells in vitro and suppressed angiogenesis in vivo animal models. Therefore, we provided both clinical and experimental evidence to indicate that Sp1 might impact gastric cancer development and progression through regulating angiogenesis, a critical aspect of cancer biology.

KW - Angiogenesis

KW - Metastasis

KW - Prognosis

KW - Transcription factor

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=23844489046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844489046&partnerID=8YFLogxK

U2 - 10.1007/s10585-005-5684-3

DO - 10.1007/s10585-005-5684-3

M3 - Article

C2 - 16158248

AN - SCOPUS:23844489046

VL - 22

SP - 205

EP - 213

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 3

ER -